Cartesian Therapeutics (RNAC) Amortizatization of Intangibles (2016 - 2026)

Cartesian Therapeutics (RNAC) has 11 years of Amortizatization of Intangibles data on file, last reported at $235000.0 in Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles rose 27.72% year-over-year to $235000.0 in Q1 2026; TTM through Mar 2026 was $829000.0, a 60.69% decrease from a year earlier, with the FY2025 full-year figure at $778000.0, down 68.08% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $235000.0, up from $215000.0 in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for RNAC reached as high as $1.2 million in Q4 2022 and fell as low as -$1.2 million in Q4 2023.
• Historically, Amortizatization of Intangibles has averaged $286235.3 across 5 years, with a median of $235000.0 in 2026.
• Across the five-year window, Amortizatization of Intangibles plunged 5044.44% in 2022 and surged 41700.0% in 2023, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $1.2 million in 2022, then plunged by 199.17% to -$1.2 million in 2023, then soared by 155.96% to $671000.0 in 2024, then plunged by 67.96% to $215000.0 in 2025, then climbed by 9.3% to $235000.0 in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $235000.0 in Q1 2026, $215000.0 in Q4 2025, and $192000.0 in Q3 2025.